News

The FDA is reconsidering the black box warning on estrogen. Experts say it’s time for a change—find out what this means for ...
A panel of 12 experts in the menopause field reexamined the findings of the 2002 Women’s Health Initiative study that said ...
Members of an FDA expert panel discussed reassessing boxed warnings for menopausal HT and how to better educate patients and ...
Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.
JUUL GETS ITS CROWN — The FDA authorized Juul’s applications on Thursday to sell e-cigarettes in the U.S., determining ...
While Astellas’ Veozah was the first neurokinin 3 (NK-3) receptor antagonist approved for menopause, Lynkuet is the first ...
Explore ways men over 40 can boost testosterone and hormone balance — diet, exercise, sleep, stress, and TRT for energy, ...
The FDA has granted priority review to an application for Revuforj for the treatment of relapsed or refractory mutant NPM1 acute myeloid leukemia.
An article in The Journal For Nurse Practitioners found that Depo-Testosterone was the most cost-efficient TRT option, and ...
These symptoms could also be due to lowered testosterone levels. A 2023 study in the Journal of Clinical Endocrinology ...
Note that some links may require registration or subscription. A New York man who entered an MRI room while a scan was taking ...
Novartis is launching a $10 billion share buyback to be completed by year-end 2027 as new drug launches accelerate. | ...